Total Triiodothyronine (T3)
Males, Age 30-39
The median total T3 for males aged 30-39 in the US population is 117.0 ng/dL, with 90% of this group falling between 89.6 and 157.9 ng/dL.
NHANES 2009-2012 Thyroid Profile (Subsample A) 2009-2012 · Sample size: 289 participants · Unit: ng/dL
Percentile Distribution
| Percentile | P5 | P10 | P25 | P50 | P75 | P90 | P95 |
|---|---|---|---|---|---|---|---|
| Value (ng/dL) | 89.6 | 96.4 | 105.3 | 117 | 133 | 147 | 157.9 |
| 95% CI | 71.5 | 88 | 102.8 | 113 | 127 | 140.8 | 149.1 |
| Percentile | Value (ng/dL) | 95% CI |
|---|---|---|
| P5 | 89.6 | 71.5 |
| P10 | 96.4 | 88 |
| P25 | 105.3 | 102.8 |
| P50 | 117 | 113 |
| P75 | 133 | 127 |
| P90 | 147 | 140.8 |
| P95 | 157.9 | 149.1 |
The 95% confidence interval (CI) is the range of values for the population percentile that are consistent with this sample, given how NHANES selected participants. It describes uncertainty in the percentile, not in any one person's result.
105.3 117 133
P25 P50 P75
P5 89.6 P95 157.9
Data and Methodology
- Dataset
- NHANES 2009-2012 Thyroid Profile (Subsample A) ( NHANES 2009-2012 Thyroid 2009 , Survey-weighted percentiles from NHANES 2009-2012 Thyroid Profile Subsample A)
- Survey years
- 2009-2012
- Measurement
- Measured by competitive binding immunoenzymatic assay on Beckman Coulter Access. How it was measured
- Sample size
- 289 participants
- Reference population
- US males aged 30-39, excluding pregnant participants, those with self-reported thyroid disease, and current thyroid medication users
- Exclusion criteria
-
- Age under 20
- Pregnant at time of exam (RIDEXPRG == 1)
- Self-reported thyroid disease (MCQ160M == 1)
- Current thyroid medication use (RXDDRUG match against thyroid_drug_list.txt)
- Missing analyte value
- Missing or zero subsample weight (WTSA2YR)
- Notes
- Percentiles computed using the Subsample A two-year weight (WTSA2YR), divided by 2 to pool the 2009-2010 and 2011-2012 cycles.